Norris Wong

By Paul Rainville, Brianna Clements, Adam Bengtson, and Norris Wong, Waters Corporation Glucagon-Like Peptide-1 agonists (GLP-1s) are a class of synthetic peptide medications widely prescribed for managing obesity and type-II diabetes. Recently, drugs like semaglutide have gained significant attention as effective weight management treatments, following promising results in clinical trials.

By Paul Rainville, Brianna Clements, Adam Bengtson, and Norris Wong, Waters Corporation Glucagon-Like Peptide-1 agonists (GLP-1s) are a class of synthetic peptide medications widely prescribed for managing obesity and type-II diabetes. Recently, drugs like semaglutide have gained significant attention as effective weight management treatments, following promising results in clinical trials.